Johnson & Johnson Price to Free Cash Flow Ratio 2006-2018 | JNJ

Historical price to free cash flow ratio values for Johnson & Johnson (JNJ) since 2006.
Johnson & Johnson Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2019-02-22 136.60 8.10
2018-09-30 137.30 $16.86 8.14
2018-06-30 119.77 $16.53 7.25
2018-03-31 125.57 $15.97 7.86
2017-12-31 136.04 $15.75 8.64
2017-09-30 125.82 $14.63 8.60
2017-06-30 127.21 $13.55 9.39
2017-03-31 118.99 $12.95 9.19
2016-12-31 109.35 $12.65 8.65
2016-09-30 111.35 $13.58 8.20
2016-06-30 113.58 $14.67 7.74
2016-03-31 100.60 $15.44 6.52
2015-12-31 94.82 $15.74 6.03
2015-09-30 85.55 $15.63 5.47
2015-06-30 88.62 $16.36 5.42
2015-03-31 90.81 $16.41 5.53
2014-12-31 93.74 $16.70 5.61
2014-09-30 94.93 $14.81 6.41
2014-06-30 92.55 $13.02 7.11
2014-03-31 86.30 $12.16 7.10
2013-12-31 79.89 $11.63 6.87
2013-09-30 75.09 $11.63 6.46
2013-06-30 73.82 $11.66 6.33
2013-03-31 69.57 $11.92 5.84
2012-12-31 59.34 $12.25 4.85
2012-09-30 57.83 $11.87 4.87
2012-06-30 56.19 $11.45 4.91
2012-03-31 54.33 $10.99 4.95
2011-12-31 53.55 $10.75 4.98
2011-09-30 51.53 $11.37 4.53
2011-06-30 53.34 $11.95 4.46
2011-03-31 47.10 $12.45 3.78
2010-12-31 48.73 $12.95 3.76
2010-09-30 48.40 $12.89 3.76
2010-06-30 45.70 $12.27 3.72
2010-03-31 50.00 $11.73 4.26
2009-12-31 49.01 $11.38 4.31
2009-09-30 45.97 $10.70 4.29
2009-06-30 42.54 $10.41 4.08
2009-03-31 39.05 $10.29 3.80
2008-12-31 44.05 $10.40 4.23
2008-09-30 50.60 $10.23 4.94
2008-06-30 46.70 $10.26 4.55
2008-03-31 46.75 $10.54 4.44
2007-12-31 47.76 $10.80 4.42
2007-09-30 46.75 $10.58 4.42
2007-06-30 43.56 $10.17 4.28
2007-03-31 42.32 $9.77 4.33
2006-12-31 46.09 $9.54 4.83
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $365.814B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $251.211B 14.07
Merck (MRK) United States $214.158B 18.30
Novartis AG (NVS) Switzerland $209.609B 17.83
Eli Lilly (LLY) United States $127.004B 22.06
Novo Nordisk (NVO) Denmark $121.443B 19.64
AbbVie (ABBV) United States $120.322B 10.11
Sanofi (SNY) France $105.716B 13.05
AstraZeneca (AZN) United Kingdom $102.658B 11.71
GlaxoSmithKline (GSK) United Kingdom $102.598B 13.47
Bristol-Myers Squibb (BMY) United States $83.732B 12.89